Recommendations to countries and the WHO to ensure that treatment options are accessible and affordable for people living with diabetes.

Pharmaceutical corporation AstraZeneca and the University of Oxford announced today that combined data from an interim analysis of a phase 2/3 trial in the United Kingdom (UK) and a phase 3 trial in Brazil suggested that their ...

Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic.